Trials / Completed
CompletedNCT03281005
Development of Visual Function Evaluation Method
Calibration of Visual Function Evaluation Tests in Patients With Severe Vision Loss
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to develop the comprehensive visual function evaluation method in severe visually impaired patient
Detailed description
This study is a prospective observational study which consists of 4 Parts; Part 1A, 1B, 2 and 3. Part 1A has been conducted on 6 subjects diagnosed with retinitis pigmentosa. Additional examination will be performed using alternative devices imported outside Japan on subjects who completed Part 1A and re-consented (Part 1B). Based on the interim result of Part 1A, Part 2 will be conducted on another 6 subjects with retinitis pigmentosa with improved methodology and the devices used in Part 1B. Part 3 will be conducted in 6 healthy volunteers to obtain comparative data using devices used in Part 1B.
Conditions
Timeline
- Start date
- 2017-11-01
- Primary completion
- 2019-11-21
- Completion
- 2019-11-21
- First posted
- 2017-09-13
- Last updated
- 2024-10-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03281005. Inclusion in this directory is not an endorsement.